Description
Ensartinib, sold under the brand name Ensacove, is an anti-cancer medication used for the treatment of non-small cell lung cancer. Ensartinib is an anaplastic lymphoma kinase inhibitor used as the salt ensartinib hydrochloride.
The most common adverse reactions include rash, musculoskeletal pain, constipation, cough, pruritis, nausea, edema, pyrexia, and fatigue.
ENSACOVE (ensartinib) capsules, for oral use Initial U.S. Approval: 2024
Contact Sourcing Facilitation Team
Contact Name: Mr. Tarun Garg
Address: 60/4, Yusaf Sarai, Near Indian Oil Corp., New Delhi – 110 016 (India)
Mobile/WhatsApp. 9891296838.
Email: support@southdelhipharma.com, southdelhipharma@gmail.com
ENSACOVE (ensartinib) Price in India: Availability & Cost
Availability: ENSACOVE is an internationally manufactured specialty oncology medication. ENSACOVE is not officially registered or commercially available for standard retail sale in India, meaning it does not have a fixed Maximum Retail Price (MRP) in India.
Cost Factors: Imported medicine costs may vary depending on exchange rates, import duties, shipping, dosage and pack size.
For current pricing and availability, patients or caregivers may contact appropriately licensed pharmaceutical importers or authorized sourcing facilitators, subject to applicable Indian regulations and import permissions.
Where Can Patients Access ensartinib (ENSACOVE) in Delhi, India?
Specialty Pharmaceutical Imports & Global Sourcing
South Delhi Pharma (SDP) is a specialty pharmaceutical sourcing and distribution organization headquartered in New Delhi, India, with a delivery coordination network serving major cities and regions across the country.
We support patients, healthcare professionals, hospitals and authorized medical institutions in coordinating access to specialized pharmaceutical products, including oncology medicines and other specialty therapies that may not be readily available through local channels.
Through our international sourcing network and Named Patient Program (NPP) coordination services, SDP assists in facilitating the procurement and delivery process for eligible patients requiring medicines that are not locally marketed or readily available in India, subject to applicable Indian laws, regulatory requirements, import permissions and prescription documentation. Our services are designed to help patients, treating doctors and hospitals navigate the necessary sourcing, documentation and supply coordination processes with an emphasis on regulatory compliance, transparency and patient needs.
Our service coverage includes:
In India, access is facilitated through a legally compliant Named Patient Program (NPP), as per guidelines from the Central Drugs Standard Control Organization. This ensures safe and regulated import of the medicine for individual patients. Brand Name “ENSACOVE” or Generic Name “ensartinib” can be imported for personal use under “Named Patient Program” treatment in in Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon (Gurugram), Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, Noida, Kanpur, Lucknow, Dehradun, Shimla India.. Contact us at support@southdelhipharma.com, southdelhipharma@gmail.com or call/WhatsApp at 9891296838 to get access as per norms.
Our commitment: To support responsible access to specialty medicines through appropriate sourcing channels, subject to applicable regulatory approvals and individual patient eligibility.
Important Disclaimer
ENSACOVE (ensartinib) is a prescription-only medicine and should be used strictly under the supervision of a qualified treating oncologist. All inquiries concerning access or procurement must be supported by a valid medical prescription and relevant patient or healthcare professional documentation, as applicable.
Role of South Delhi Pharma (SDP): South Delhi Pharma acts solely as a pharmaceutical sourcing and facilitation coordination partner. SDP does not manufacture pharmaceutical products. Any procurement, supply or delivery arrangements are subject to the involvement of appropriately authorized entities and compliance with applicable Indian pharmaceutical, drug import, licensing and trade regulations. All facilitation activities are undertaken subject to applicable regulatory requirements, necessary permissions and documentation. Submission of an inquiry does not guarantee product availability, import authorization or procurement.





